26
Treatment
Table 5. Routine Healthcare Maintenance for People With
HIV (After Initial Assessment)
Intervention Recommendation Comments
Screening and Vaccination for Infectious Diseases (cont'd)
Trichomoniasis
screening
Perform annually for persons having
vaginal sex.
Screen using NAAT testing.
Hepatitis A, B
and C screening
Hepatitis C: In sexually active,
HCV negative men having sex
with men, transgender women, and
PWID. Screen annually.
In those with new abnormal
liver function test, check
for acute HAV, HBV, and
HCV.
Tuberculosis
screening
Perform annually in patients at risk
for tuberculosis.
Either TST or IGRA.
Vaccinations
For most current
vaccination
recommendations,
consult current
vaccination
schedules
Pneumococcus (PCV13 and
PPV23): Repeat PPV23 once 5 years
aer first vaccination. All patients
with HIV should receive one dose of
PCV13. If not vaccinated previously,
this should be the first dose. If never
vaccinated, one dose PCV13 at least
one year aer PPV23.
—
Influenza: Administer annually.
Avoid live influenza vaccine
if CD4 <200/µL.
Tetanus-diphtheria-whooping
cough: Administer Tdap once
followed by Td or Tdap every 10
years and as indicated for wound
management.
—
Meningococcal Vaccine
(MenACWY) × 2 doses; booster
every 5 years depending on risk.
—
Hepatitis A and B: Administer if
not immune.
Check anti-HBs 1–2
months or next scheduled
visit aer completion of
series. Administer hepatitis
A and B boosters based on
immune status.
HPV vaccine: Administer if age
≤26 years. Consider administering
if age 27–45 and unvaccinated or
inadequately vaccinated.
HPV vaccine now
recommended up to age 45.
SARS CoV-2 vaccine: Administer
regardless of HIV-1 RNA and CD4
count, in accordance with ACIP
guidelines
—
Varicella zoster: Shingrix
®
vaccine
× 2 doses if over age 50 and CD4
>200/µL.
e ACIP has not made a
recommendation for CD4
≤200/µL.
(cont'd)
